These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16973326)

  • 1. Contrast agents for functional and cellular MRI of the kidney.
    Grenier N; Pedersen M; Hauger O
    Eur J Radiol; 2006 Dec; 60(3):341-52. PubMed ID: 16973326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of glomerular filtration rate with magnetic resonance imaging: principles, limitations, and expectations.
    Grenier N; Mendichovszky I; de Senneville BD; Roujol S; Desbarats P; Pedersen M; Wells K; Frokiaer J; Gordon I
    Semin Nucl Med; 2008 Jan; 38(1):47-55. PubMed ID: 18096463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of renal function.
    Bennett HF; Li D
    Magn Reson Imaging Clin N Am; 1997 Feb; 5(1):107-26. PubMed ID: 8995128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR contrast agents, the old and the new.
    Bellin MF
    Eur J Radiol; 2006 Dec; 60(3):314-23. PubMed ID: 17005349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated colorimetric gadolinium assay for verification of clearance and estimation of glomerular filtration rate.
    Magnotti RA; Connell JL; Marietta PM
    Clin Chim Acta; 2009 Jan; 399(1-2):59-63. PubMed ID: 18834869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional renal MR imaging.
    Huang AJ; Lee VS; Rusinek H
    Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):469-86, vi. PubMed ID: 15271366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
    Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
    J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI of the kidney and urinary tract.
    Israel GM
    J Magn Reson Imaging; 2006 Oct; 24(4):725-34. PubMed ID: 16947313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging.
    Stoll G; Bendszus M
    Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of gadolinium hydroxypyridonate chelates: initial experience as contrast media in magnetic resonance imaging.
    Thompson MK; Misselwitz B; Tso LS; Doble DM; Schmitt-Willich H; Raymond KN
    J Med Chem; 2005 Jun; 48(11):3874-7. PubMed ID: 15916439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional MRI of the kidney.
    Grenier N; Basseau F; Ries M; Tyndal B; Jones R; Moonen C
    Abdom Imaging; 2003; 28(2):164-75. PubMed ID: 12592462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of extraction fraction (EF) and glomerular filtration rate (GFR) using MRI: considerations derived from a new Gd-chelate biodistribution model simulation.
    Buonocore MH; Katzberg RW
    IEEE Trans Med Imaging; 2005 May; 24(5):651-66. PubMed ID: 15889552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging with targeted contrast agents.
    Makowski MR; Wiethoff AJ; Jansen CH; Botnar RM
    Top Magn Reson Imaging; 2009 Aug; 20(4):247-59. PubMed ID: 20805735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRU post-processing.
    Jones RA; Schmotzer B; Little SB; Grattan-Smith JD
    Pediatr Radiol; 2008 Jan; 38 Suppl 1():S18-27. PubMed ID: 18071692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR-based semi-automated quantification of renal functional parameters with a two-compartment model--an interobserver analysis.
    Attenberger UI; Sourbron SP; Notohamiprodjo M; Lodemann KP; Glaser CG; Reiser MF; Schoenberg SO; Michaely HJ
    Eur J Radiol; 2008 Jan; 65(1):59-65. PubMed ID: 18022338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular magnetic resonance imaging with targeted contrast agents.
    Artemov D
    J Cell Biochem; 2003 Oct; 90(3):518-24. PubMed ID: 14523986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential.
    Mohs AM; Lu ZR
    Expert Opin Drug Deliv; 2007 Mar; 4(2):149-64. PubMed ID: 17335412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.